The group’s principle activity is to serve the nuclear medicine industry by producing pharmaceutical products. The group’s products include BMS(R)Technelite Sodium Pertechnetate (99mTcO4_) and Ceretec(R) (Kit for the Preparation of Tc-99m Exametazime). The group operates from United States.
